Robert W. Buckheit

9.9k total citations
190 papers, 8.2k citations indexed

About

Robert W. Buckheit is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Robert W. Buckheit has authored 190 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Infectious Diseases, 125 papers in Virology and 47 papers in Molecular Biology. Recurrent topics in Robert W. Buckheit's work include HIV Research and Treatment (125 papers), HIV/AIDS drug development and treatment (112 papers) and HIV/AIDS Research and Interventions (56 papers). Robert W. Buckheit is often cited by papers focused on HIV Research and Treatment (125 papers), HIV/AIDS drug development and treatment (112 papers) and HIV/AIDS Research and Interventions (56 papers). Robert W. Buckheit collaborates with scholars based in United States, Belgium and Spain. Robert W. Buckheit's co-authors include Michael R. Boyd, Karen Watson, James B. McMahon, Jim A. Turpin, Kirk R. Gustafson, Raymond C. Sowder, Tracy L. Hartman, Barry R. O’Keefe, Michael J. Currens and Toshiyuki Mori and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Robert W. Buckheit

188 papers receiving 7.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert W. Buckheit United States	47	3.0k	3.0k	2.9k	2.1k	1.1k	190	8.2k
Jan Balzarini Belgium	46	2.2k 0.7×	3.8k 1.3×	1.2k 0.4×	2.7k 1.3×	1.4k 1.3×	213	7.6k
James B. McMahon United States	55	1.7k 0.6×	4.4k 1.5×	1.8k 0.6×	2.5k 1.2×	819 0.8×	177	9.5k
Myriam Witvrouw Belgium	53	3.4k 1.1×	2.6k 0.9×	3.1k 1.1×	2.7k 1.3×	974 0.9×	192	8.1k
Barry R. O’Keefe United States	43	917 0.3×	3.5k 1.2×	1.1k 0.4×	1.4k 0.7×	762 0.7×	157	6.1k
David A. Fidock United States	71	2.5k 0.8×	3.7k 1.3×	732 0.3×	1.3k 0.6×	2.0k 1.9×	217	17.2k
Masanori Baba Japan	62	6.9k 2.3×	5.0k 1.7×	5.9k 2.0×	3.6k 1.7×	3.3k 3.1×	372	16.0k
Graciela Andreï Belgium	58	3.0k 1.0×	4.1k 1.4×	1.6k 0.6×	4.6k 2.2×	4.7k 4.3×	509	13.0k
Rudi Pauwels Belgium	63	9.2k 3.1×	4.4k 1.5×	8.1k 2.8×	2.8k 1.3×	3.4k 3.2×	145	14.9k
Lieve Naesens Belgium	53	3.5k 1.2×	3.2k 1.1×	1.3k 0.5×	2.2k 1.0×	4.4k 4.1×	284	9.6k
Jim A. Turpin United States	36	1.5k 0.5×	1.4k 0.5×	1.9k 0.6×	730 0.3×	617 0.6×	91	4.3k

Countries citing papers authored by Robert W. Buckheit

Since Specialization

Citations

This map shows the geographic impact of Robert W. Buckheit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Buckheit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Buckheit more than expected).

Fields of papers citing papers by Robert W. Buckheit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Buckheit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Buckheit. The network helps show where Robert W. Buckheit may publish in the future.

Co-authorship network of co-authors of Robert W. Buckheit

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Buckheit. A scholar is included among the top collaborators of Robert W. Buckheit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Buckheit. Robert W. Buckheit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guthrie, Kate M., Rochelle K. Rosen, Sara Vargas, et al.. (2021). Designing Dual Compartment HIV Prevention Products: Women's Sensory Perceptions and Experiences of Suppositories for Rectal and Vaginal Use. AIDS Research and Human Retroviruses. 38(7). 601–610. 1 indexed citations

Guthrie, Kate M., Joseph L. Fava, Sara Vargas, et al.. (2020). The Role of Volume in the Perceptibility of Topical Vaginal Formulations: User Sensory Perceptions and Experiences of Heterosexual Couples During Vaginal Sex. AIDS Research and Human Retroviruses. 36(12). 1059–1070. 1 indexed citations

Shieh, Eugenie, Edward J. Fuchs, Mark A. Marzinke, et al.. (2020). Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human Study. AIDS Research and Human Retroviruses. 37(6). 444–452. 6 indexed citations

Pereira, Lara, Amy Martin, Chuong Dinh, et al.. (2018). Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques. Drug Delivery and Translational Research. 8(5). 1180–1190. 5 indexed citations

Shieh, Eugenie, et al.. (2017). Lubricant Provides Poor Rectal Mucosal HIV Coverage. AIDS Research and Human Retroviruses. 33(8). 784–787. 8 indexed citations

Walker-Sperling, Victoria E., Christian A. Merlo, Robert W. Buckheit, et al.. (2016). Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages. AIDS Research and Human Retroviruses. 32(10-11). 1097–1099. 3 indexed citations

Guthrie, Kate M., Joseph L. Fava, Sara Vargas, et al.. (2016). A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and Acceptability. AIDS Research and Human Retroviruses. 33(5). 440–447. 10 indexed citations

Ham, Anthony S., Jennifer J. Peters, David F. Katz, et al.. (2015). The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention. Antiviral Research. 120. 153–164. 21 indexed citations

Morrow, Kathleen M., Rochelle K. Rosen, Sara Vargas, et al.. (2014). More…? Less…? Just Right…? The Role of Perceived Volume in Gel and Film Perceptibility During Intercourse, and its Impact on Product Preference. AIDS Research and Human Retroviruses. 30(S1). A145–A145. 5 indexed citations

10.

Morrow, Kathleen M., Lisa C. Rohan, Rochelle K. Rosen, et al.. (2014). Vaginal Film User Evaluations: Developer Considerations from Initial Impressions and User Sensory Perceptions and Experiences during Vaginal Sex. AIDS Research and Human Retroviruses. 30(S1). A145–A146. 1 indexed citations

11.

Morrow, Kathleen M., Rochelle K. Rosen, Joseph L. Fava, et al.. (2014). “He Said, She Said.” Exploring Couples' Sensory Perceptions and Experiences with Vaginal Gels & Film: Implications for Microbicide Development. AIDS Research and Human Retroviruses. 30(S1). A86–A87. 2 indexed citations

12.

Buckheit, Robert W., et al.. (2014). IND-directed Pharmacology and Toxicology of IQP-0528, a Novel HIV-1 Topical Microbicide. AIDS Research and Human Retroviruses. 30(S1). A261–A261. 1 indexed citations

13.

Salgado, María, Shiv Gandhi, Robert W. Buckheit, Gail Berkenblit, & Joel N. Blankson. (2013). Evolution of an Attenuated HIV-1 Isolate in an Elite Suppressor. AIDS Research and Human Retroviruses. 30(3). 284–288. 3 indexed citations

14.

Tien, Deborah, Roger L. Schnaare, Feirong Kang, et al.. (2005). In Vitro and in Vivo Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical Trials. AIDS Research and Human Retroviruses. 21(10). 845–853. 157 indexed citations

15.

Xu, Guozhang, et al.. (2002). Synthesis of alkenyldiarylmethane (ADAM) non-Nucleoside HIV-1 reverse transcriptase inhibitors with non-Identical aromatic rings. Bioorganic & Medicinal Chemistry. 10(2). 283–290. 17 indexed citations

16.

Palmer, Sarah, et al.. (2001). Tenofovir, Adefovir, and Zidovudine Susceptibilities of Primary Human Immunodeficiency Virus Type 1 Isolates with Non-B Subtypes or Nucleoside Resistance. AIDS Research and Human Retroviruses. 17(12). 1167–1173. 37 indexed citations

17.

Buckheit, Robert W., et al.. (1994). Potent and Specific Inhibition of HIV Envelope-Mediated Cell Fusion and Virus Binding by G Quartet-Forming Oligonucleotide (ISIS 5320). AIDS Research and Human Retroviruses. 10(11). 1497–1506. 74 indexed citations

18.

Kucera, Louis S., Shelby Puckett, Robert W. Buckheit, et al.. (1993). Activity of Triciribine and Triciribine-5′ -Monophosphate Against Human Immunodeficiency Virus Types 1 and 2. AIDS Research and Human Retroviruses. 9(4). 307–314. 15 indexed citations

19.

Buckheit, Robert W., et al.. (1993). Differential Antiviral Activity of Two TIBO Derivatives Against the Human Immunodeficiency and Murine Leukemia Viruses Alone and in Combination with Other Anti-HIV Agents. AIDS Research and Human Retroviruses. 9(11). 1097–1106. 16 indexed citations

20.

Buckheit, Robert W., et al.. (1991). Characterization of an HIV-1 Isolate Displaying an Apparent Absence of Virion-Associated Reverse Transcriptase Activity. AIDS Research and Human Retroviruses. 7(3). 295–302. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact